Scinai Immunotherapeutics Ltd. (SCNI) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Corporate company logo of Scinai Immunotherapeutics Ltd (SCNI)

The market valuation chart for Scinai Immunotherapeutics (SCNI), whose operations are based on creating targeted immunotherapy via the NanoAb platform and patent protection for B2B projects, demonstrates the 0.00 metric. Future growth relies on the success of nano-antibodies against autoimmune pathologies and viral infections, as well as the volume of grants. Meanwhile, business stability is constrained by debt and a reliance on third-party manufacturing sites during the development of dermatitis therapy.

SCNI BiondVax Pharmaceuticals: Enterprise Value to EBITDA Ratio in the range 11/23/2025 - 11/16/2026

Scinai Immunotherapeutics Ltd. - analytical breakdowns and key metrics (SCNI)

- current price and projected stock value:
Initial company analysis:SCNI (scinai.com)
Original product of scinai.com

The development of the nanoantibody platform by Scinai Immunotherapeutics (SCNI) to combat pandemics is reflected in the enterprise value-to-EBITDA ratio. This indicator aggregates market capitalization with debt and taxes, comparing the total cost of acquiring the business against its operating profit. A decrease in the ratio signals that assets are undervalued, whereas a sharp increase indicates an overpayment for the company's innovative potential.

Analysis of competing companies

EV/EBITDA Multiple ARGX (argenx.com)|Total Company Value to Operating Income Before Depreciation Ratio biontech.de (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ADMA Biologics Inc (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist Corp (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant, Inc.|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple grifols.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies Corp (ADPT)|Celldex Therapeutics, Inc. - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (auriniapharma.com)|BioCryst Pharmaceuticals Inc (BCRX) - Company Value to EBITDA|VERA: Enterprise Value to EBITDA Ratio|DNTH (Dianthus Therapeutics) - Enterprise Value to Operating Income Before Depreciation|PHVS: EV/EBITDA Multiple|ABCL (AbCellera Biologics Inc.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio TRML|Company Value to EBITDA Intrexon PGEN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming Group N.V. (PHAR)|Enterprise Value to Operating Income Before Depreciation Ratio NKTR|EV/EBITDA Multiple UPB (Upstream Pharma)|Total Company Value to Operating Income Before Depreciation Ratio Zenas Biopharma, Inc. (ZBIO)|IMNM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Gossamer Corp (GOSS) - Enterprise Value to EBITDA Ratio|KALV (KalVista Pharmaceuticals Inc) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation SEPN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pieris Pharmaceuticals|Savara Inc (SVRA) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RIGL|Total Company Value to Operating Income Before Depreciation Ratio AnaptysBio Inc.|EV/EBITDA Multiple ATXS (Astria Therapeutics Inc)|enGene Holdings Inc. - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|RAPT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation JBIO (aerovatetx.com)|Aclaris (ACRS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Kyverna - Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio TLSA|Company Value to EBITDA Cabaletta Bio CABA|EV/EBITDA Multiple VTYX|Theratechnologies (THTX) - Enterprise Value to EBITDA Multiple|Avalo Therapeutics - Enterprise Value to EBITDA Ratio|Eledon Pharmaceuticals (ELDN) - Company Value to EBITDA|Agenus, Inc - EV/EBITDA Multiple|Company Value to EBITDA climbbio.com|ZURA (Zura Bio Limited) - Enterprise Value to EBITDA Ratio|aTyr (ATYR) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio ADAG|IMA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Shattuck Therapeutics (STTK)|Enterprise Value to EBITDA Ratio Equillium EQ|Connect Biopharma Holdings Limited - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation IMUX|ATRA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|inflarx.de (IFRX) - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation X4 Pharmaceuticals XFOR|ACET - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization celularity.com|INMB: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple BRNS|EV/EBITDA Multiple Kezar Life Sciences Inc (KZR)|EV/EBITDA Multiple SABS (SAB Biotherapeutics)|EV/EBITDA Multiple akaritx.com AKTX|Enlivex Therapeutics Ltd. - EV/EBITDA Multiple|QTTB - EV/EBITDA Multiple|GOVX (GeoVax Labs Inc) - Enterprise Value to EBITDA Ratio|Enterprise Value to EBITDA Ratio Edesa|IBIO (iBio, Inc.) - EV/EBITDA Multiple|CARM: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple XTLB|Enterprise Value to EBITDA Ratio Bolt Biotherapeutics, Inc. BOLT|EV/EBITDA Multiple HCWB (hcwbiologics.com)|Business Value to Operating Income Before Depreciation APVO|AIM ImmunoTech, Inc. - EV/EBITDA Multiple|ADTX (Aditxt Inc.) - Enterprise Value to Operating Income Before Depreciation|GRI: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio XORTX Therapeutics|Enterprise Value to EBITDA Ratio HIND|REVB: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization indaptusrx.com (INDP)|Enterprise Value to EBITDA Ratio CalciMedica CALI|EV/EBITDA Multiple AFMD (affimed.com)|Allakos Inc. (ALLK) - Company Value to EBITDA|HOOKIPA - EV/EBITDA Multiple|IGMS (igmbio.com) - Enterprise Value to Operating Income Before Depreciation|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation OCEA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC BioPharm|Third Harmonic Bio Inc. (THRD) - Total Company Value to Operating Income Before Depreciation Ratio